Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia HLA
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity BLOOD ADV
Monocyte subset distribution in myeloproliferative and myelodysplastic/myeloproliferative neoplasms with monocytosis LEUKEMIA RES